Navigation Links
Genoptix Announces Participation at the UBS Global Life Sciences Conference
Date:9/16/2008

CARLSBAD, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the UBS Global Life Sciences Conference scheduled to take place at the Grand Hyatt in New York City on September 22 - 25, 2008.

Douglas Schuling, Senior Vice President and CFO of Genoptix, will present at the conference on Monday, September 22, beginning at approximately 3:30 pm EDT. Mr. Schuling will provide an overview of the Company's specialized diagnostic laboratory service offerings, growth strategies and past operational performance.

The presentation is expected to last approximately 30 minutes, followed by a 30 minute break-out session. The presentation will be web cast live and made accessible through the investor relations section of the Genoptix website at http://www.genoptix.com. Those who would like to listen to the presentation should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. A replay will also be available for 30 days following the initial presentation web cast.

About Genoptix, Inc.

Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community- based hematologists and oncologists. Genoptix is headquartered in Carlsbad, California.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Genoptix disclaims, however, any intent or obligation
'/>"/>

SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Genoptix Reports Strong Financial Results For Third Quarter 2007
2. Boston Scientific Announces Court Decision
3. 3SBio Inc. Announces Results of Annual General Meeting
4. CMS, Inc., an Elekta Company, Announces Commercial Availability of Focal4D(TM)
5. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
6. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
7. CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
8. Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
9. Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit
10. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
11. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...NSTER, Germany, November 19 MONITO...November 16th, 2009 Flibanserin in the,indication ...Parkinson,s,disease for orphan drug status designa...vodopa-induced dyskinesia is a complication of the...serious burden to some of those,affected, since it...
(Date:11/19/2009)...IENNA, Austria, November 19 AFFiRi... one product candidate at an unexpectedly early,st...planned to enter into,Phase II clinical trial earl...y follows the completion of two Phase I trials wit...its fast decision on the first interim,analysis of...
(Date:11/18/2009)...n,s University Belfast are developing new sensors ...will help in the fight against the threat of terro... pads to ,swipe, an individual or crime scene to g...g instrument that can detect the presence of chemi...r decisions to be made in response to terrorist th...
(Date:11/18/2009)...YORK, Nov. 18 Reportlinker.com ann...ble in its catalogue. ,, Biotechnology Reagen...www.reportlinker.com/p0164375/Biotechnology-Reagen...rnewswire&utm_medium=pr&utm_campaign=prnew...omplex chemical compounds used in a range of biote...
Breaking Biology Technology:MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8
...LLEGEVILLE, Pa., Sept. 8 Wyeth Pharmaceuticals, a...that product shipments have,begun for XYNTHA(TM) A...Free, a new recombinant factor VIII product for bo... and surgical prophylaxis in,patients with hemophi... XYNTHA is produced using state-of-the-art manufa...
... SACHEM announced today th...arning program. With the growing popularity of SAC...fering scientists worldwide the ability to learn m...two dimensional High Performance Liquid Chromatogr...N, Texas (Business Wire EON) September 8, 2008 -- ...
...mpany CEO is featured speaker: ,Ion Channel Panels... on Tuesday, September 9th at 2:30, CLEVELAND, Se...ted ion channel-expressing cell lines and services...will exhibit its expanding line of ion,channel ser... Targets,conference in San Francisco September 9 a...
Other Biology Technology:New Recombinant XYNTHA Now Available for Patients with Hemophilia A 2New Recombinant XYNTHA Now Available for Patients with Hemophilia A 3New Recombinant XYNTHA Now Available for Patients with Hemophilia A 4New Recombinant XYNTHA Now Available for Patients with Hemophilia A 5 SACHEM Launches 2-D HPLC e-Learning Program : New e-Learning Program Teaches Scientists How to Better Analyze and Prove Product Purity Through Greater Sensitivity and Precision in Identification of Trace Components 2ChanTest to Highlight the World's Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Ion Channel Targets, Booth 5 2ChanTest to Highlight the World's Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Ion Channel Targets, Booth 5 3
(Date:11/20/2009)... , In a research report published in the November....genetics.org ), scientists show how a family of g...or ACS genes) are responsible for production of et...elopment, and this information lays the foundation...lants disease resistant, able to survive and thriv...
(Date:11/20/2009)... , Using highly precise measurements of plasma li...netic resonance spectroscopy (NMR), researchers le...l and Harvard Medical School in Boston, MA, the Fr...DIS consortium in Stockholm, Sweden and Oxford, En...s the whole genome among 17,296 women of European ...
(Date:11/20/2009)... , Researchers are invited to contribute their ab... (IOF WCO ECCEO10), the largest global meeting de...ritis research and patient care. The Congress will... Beginning today, abstracts can be submitted onli...mission deadline is February 4, 2010. , IOF and ...
Breaking Biology News(10 mins):It's a gas: New discovery may lead to heartier, high-yielding plants 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3National Hospice and Palliative Care Organizations Caring Connections and Google Health Offer New Way to Access Advance Directives Online 51932 1National Hospice and Palliative Care Organizations Caring Connections and Google Health Offer New Way to Access Advance Directives Online 51932 2Largest Gift in History of Reed College and National Jewish Health Received from Author David Eddings 51929 1Largest Gift in History of Reed College and National Jewish Health Received from Author David Eddings 51929 2Largest Gift in History of Reed College and National Jewish Health Received from Author David Eddings 51929 3Largest Gift in History of Reed College and National Jewish Health Received from Author David Eddings 51929 4New Option for Correcting Nearsightedness 51926 1New Option for Correcting Nearsightedness 51926 2
...earchers in Belgium have discovered that increasin...men approach the age of 70, they become less likel...e spread to the lymph nodes. But after 70, the can... if the tumours are small. , Until now, there has... involvement and this study is the first to show c...
...fense (DOD) today announced that Rice University a...t Houston will spearhead the search for innovative... for craniofacial reconstruction for soldiers woun...t of a broad, $250 million national effort to rapi...dicine to the treatment of wounded soldiers. DOD o...
.... - A new vaccine under development may provide pr...s evolving forms, according to researchers at Purd...and Prevention who discovered the new preventative...ional influenza vaccines, the new vaccine could be...reparation for a pandemic of dangerous disease-cau...
Other Biology News:Breast cancers behave differently before and after the age of 70 2Breast cancers behave differently before and after the age of 70 3Rice and UT-Houston join DOD push for regenerative medicine 2Rice and UT-Houston join DOD push for regenerative medicine 3Rice and UT-Houston join DOD push for regenerative medicine 4New vaccine may give long-term defense against deadly bird flu and its variant forms 2New vaccine may give long-term defense against deadly bird flu and its variant forms 3New vaccine may give long-term defense against deadly bird flu and its variant forms 4
... been designed to save time and provide contaminat... eliminating the recycling and resterilizing neces...idually packaged, RNase/DNase free, non-pyrogenic ...product number, created to easily match Cornings p...
...titor Assay Kits are ideal for studying or screeni...sing fluorescence polarization (FP) The homogenous...e to the ligand binding domain of human progestero...escently-tagged progesterone ligand, Fluormone PL ...
...e the proven features of the pET, BacVector ® ...efits and versatility of each expression system in... extensively tested for performance with various t...ch case, expression was similar to that obtained w...
Rabbit Anti-Shigella Polyclonal Antibody, Unconjugated from GeneTex
Biology Products: